These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3062660)

  • 1. Imipramine vs. placebo studies of childhood depression: baseline predictors of response to treatment and factor analysis of presenting symptoms.
    Hughes CW; Preskorn SH; Weller E; Weller R; Hassanein R
    Psychopharmacol Bull; 1988; 24(2):275-9. PubMed ID: 3062660
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB; Laird LK; Morton WA; Steele TE; Kellner C; Laraia MT; Ballenger JC
    Psychopharmacol Bull; 1989; 25(1):68-70. PubMed ID: 2505304
    [No Abstract]   [Full Text] [Related]  

  • 3. Maintenance imipramine treatment following postpsychotic depression.
    Siris SG; Cutler J; Owen K; Lang MP
    Psychopharmacol Bull; 1989; 25(1):85-8. PubMed ID: 2672073
    [No Abstract]   [Full Text] [Related]  

  • 4. Imipramine for treatment of chronic depression.
    Kocsis JH; Frances A; Mann JJ; Sweeney J; Voss C; Mason B; Brown RP
    Psychopharmacol Bull; 1985; 21(3):698-700. PubMed ID: 3898184
    [No Abstract]   [Full Text] [Related]  

  • 5. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE; Lyle FA; Higginbotham W
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
    Lenox RH; Shipley JE; Peyser JM; Williams JM; Weaver LA
    Psychopharmacol Bull; 1984; 20(1):79-82. PubMed ID: 6144136
    [No Abstract]   [Full Text] [Related]  

  • 12. Cortisol differentially predicts response to imipramine and alprazolam.
    Ettigi PE; Goldberg SC; Schulz PM; Hamer RM; Blackard WG
    Psychopharmacol Bull; 1988; 24(1):206-9. PubMed ID: 3290942
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD; Abrahams LM; Crupie JE; McCawley A; Proctor RC; Sathananthan GL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of responders to fluoxetine.
    Reimherr FW; Wood DR; Byerley B; Brainard J; Grosser BI
    Psychopharmacol Bull; 1984; 20(1):70-2. PubMed ID: 6371874
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific responses to imipramine and doxepin in psychoneurotic depressed patients with sleep disturbance.
    Finnerty RJ; Goldberg HL
    J Clin Psychiatry; 1981 Jul; 42(7):275-9. PubMed ID: 7240113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of bupropion and imipramine in elderly depressives.
    Branconnier RJ; Cole JO; Ghazvinian S; Spera KF; Oxenkrug GF; Bass JL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):130-3. PubMed ID: 6406441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.